Building Mass Spec AI Co-Scientists for Biopharma
Automates expert sequence-variant characterization workflows, helping scientists identify, evaluate, review, and interpret sequence variants from LC-MS data.
Automates peptide-level characterization and post-translational modification analysis.
Learn more about LiVeritas, our AI Co-Scientists, and the science behind our platform.
LiVeritas Biosciences is a scientific AI company that automates drug candidate characterization. Its AI Co-Scientists help biopharma scientists execute complex protein-characterization workflows faster and more consistently, turning analytical data into trusted scientific intelligence while keeping experts in control.
LiVeritas automates drug candidate characterization.
AI Co-Scientists are regulatory grade scientific execution software products designed around specific mass spectrometry workflows rather than general-purpose AI. Each Co-Scientist combines scientific data, validated workflows, domain knowledge, and traceable outputs to amplify scientists, not replace them.
LiVeritas currently offers LiVeritas Sylvia™ for Sequence Variant Analysis and LiVeritas Petra™ for Peptide Mapping and PTM Analysis. Additional AI Co-Scientists are in development to expand coverage across major protein characterization workflows.
LiVeritas combines real biopharma wet-lab experience, mass spectrometry expertise, validated scientific workflows, accumulated analytical knowledge, and specialized AI built specifically for regulated drug development. Our approach begins with scientific execution and creates reusable Scientific Intelligence across workflows and development programs.
Explore the latest news, publications, and milestones from LiVeritas Biosciences.
AI is creating more complex drug candidates than biopharma can efficiently characterize; LiVeritas is breaking the analytical bottleneck with a suite of Mass Spec AI Co-Scientists spanning protein characterization.
